Iterion Therapeutics, Inc.

Gowri Sukumar

Drazen Ostovic

Formulations of tegavivint, methods of making such formulations, and methods of treatment of cancer by administering the formulations.

Formulations of tegavivint

The present invention relates to crystalline forms of (9E,10E)-2,7-bis((3,5-dimethylpiperidin-1-yl)sulfonyl)anthracene-9,10-dione dioxime, pharmaceutical compositions comprising the crystalline form, processes for preparing the crystalline form and methods of use therefore.

Crystalline form of tegavivint, method of preparation, and use thereof

Lyophilized formulations of tegavivint, methods of making such formulations, and methods of treatment of cancer by administering the formulations.

Growing community of inventors

Spring, TX, United States of America

Gowri Sukumar